University of Cambridge Enterprise Fund VIII
Below is a brief overview. Please carefully read the Information Memorandum and Key Information Document to ensure you fully understand the opportunity and the risks so you can decide for yourself whether to invest.
Launched in 2012, the University of Cambridge Enterprise funds offer Cambridge alumni and investors opportunities to invest in early-stage science and technology companies as they spin out of Cambridge University, one of the top four universities in the world.
This is the eighth University of Cambridge Enterprise EIS fund. It is a partnership between Parkwalk Advisors and Cambridge Enterprise, the commercialisation arm of the University of Cambridge.
- Experienced portfolio manager
- Exclusive deal flow from the University of Cambridge
- Co-investment opportunities with institutional investors, including Parkwalk’s parent company IP Group
- Minimum investment £25,000, you can apply online
This fund is managed by Parkwalk Advisors. Cambridge Enterprise is the Portfolio Advisor.
Parkwalk is an experienced and award-winning EIS fund manager. It was founded in 2009 by Alastair Kilgour and Moray Wright, both experienced capital markets managers advising on takeovers, acquisitions and fundraising. In January 2017, Parkwalk was acquired by IP Group, a leading intellectual property commercialisation company with net assets of £1.16 billion (June 2020) and a market capitalisation of £980 million (December 2020). Later in 2017, IP Group acquired Touchstone Innovations, which was set up to invest in promising technology companies spun out of Imperial College and University College London.
Cambridge University is a hub for research and innovation. The university has a pedigree spanning over 800 years and has been home to over 100 Nobel Prize winners and discoveries such as stem cell research and IVF.
Part of the University itself, Cambridge Enterprise was launched in 2006 to help commercialise ideas and inventions developed within the university. As the portfolio advisor, Cambridge Enterprise will source and evaluate appropriate opportunities for the fund.
The objective of the University of Cambridge Enterprise Fund VIII is to invest in a portfolio of early-stage, high-growth – and hence very high risk – research-intensive companies spun out from the University of Cambridge and/or Cambridge-based research-intensive institutions or technology clusters.
The Fund will invest in opportunities related to the University, whether the company has been founded by University staff, students or alumni or has a research or development link with the University.
Risks – important
This, like all investments available through Wealth Club, is only for experienced investors happy to make their own investment decisions without advice.
EIS investments are high risk so should only form part of a balanced portfolio and you should not invest money you cannot afford to lose. They also tend to be illiquid and hard to sell and value. Before you invest, please carefully read the Risks and Commitments and the offer documents to ensure you fully understand the risks.
Tax rules can change and benefits depend on circumstances.
This EIS fund invests in early-stage businesses which are more likely to fail than larger ones. So you should expect a number of failures in the portfolio, or even be prepared for all companies to fail.
Exit could take considerably longer than the three year minimum holding period.
A summary of the main charges and savings is shown below. Some of these will be payable by the investor, whilst others by the investee companies. The investment may have additional charges and expenses: please see the provider documents, including the Key Information Document, for more details.
|Full initial charge||5%|
|Wealth Club initial saving||—|
|Net initial charge through Wealth Club||5%||Annual management charge||1.5%|
|Performance fee||20%||Investee company charges|
|Initial charge||—||Annual charge||—|
More detail on the charges
Wealth Club aims to make it easier for experienced investors to find information on – and apply for – tax-efficient investments. You should base your investment decision on the provider's documents and ensure you have read and fully understand them before investing. This review is a marketing communication. It is not advice or a personal or research recommendation to buy the investment mentioned. It does not satisfy legal requirements promoting investment research independence and is thus not subject to prohibitions on dealing ahead of its dissemination.
- University spinouts
- Target return
- Funds raised / sought
- Minimum investment